- Home
- TSHA vs HBNC Comparison
TSHA vs HBNC Comparison
Compare TSHA & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- HBNC
- Stock Information
- Founded
- TSHA 2019
- HBNC 1873
- Country
- TSHA United States
- HBNC United States
- Employees
- TSHA N/A
- HBNC N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- HBNC Major Banks
- Sector
- TSHA Health Care
- HBNC Finance
- Exchange
- TSHA Nasdaq
- HBNC Nasdaq
- Market Cap
- TSHA 728.4M
- HBNC 708.6M
- IPO Year
- TSHA 2020
- HBNC N/A
- Fundamental
- Price
- TSHA $2.94
- HBNC $15.95
- Analyst Decision
- TSHA Strong Buy
- HBNC Hold
- Analyst Count
- TSHA 7
- HBNC 2
- Target Price
- TSHA $8.71
- HBNC $18.00
- AVG Volume (30 Days)
- TSHA 2.7M
- HBNC 209.1K
- Earning Date
- TSHA 08-12-2025
- HBNC 07-23-2025
- Dividend Yield
- TSHA N/A
- HBNC 4.01%
- EPS Growth
- TSHA N/A
- HBNC 170.74
- EPS
- TSHA N/A
- HBNC 1.17
- Revenue
- TSHA $8,098,000.00
- HBNC $211,582,000.00
- Revenue This Year
- TSHA N/A
- HBNC $47.48
- Revenue Next Year
- TSHA N/A
- HBNC $4.01
- P/E Ratio
- TSHA N/A
- HBNC $13.64
- Revenue Growth
- TSHA N/A
- HBNC 19.27
- 52 Week Low
- TSHA $1.05
- HBNC $12.70
- 52 Week High
- TSHA $3.31
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- HBNC 55.53
- Support Level
- TSHA $2.69
- HBNC $14.98
- Resistance Level
- TSHA $3.12
- HBNC $16.27
- Average True Range (ATR)
- TSHA 0.17
- HBNC 0.37
- MACD
- TSHA 0.02
- HBNC 0.07
- Stochastic Oscillator
- TSHA 68.97
- HBNC 76.98
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.